CVAid vs Epocrates
CVAid vs Epocrates, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CVAid is on 52/100 and Epocrates on 69/100.
Where each one leads
CVAid
Leads on none of the measures we hold for both companies.
Epocrates
- our overall score: 69/100 against 52/100
- domain rating: 71/100 against 23/100
- funding raised: $175M against $4.0M
At a glance
| Measure | CVAid | Epocrates |
|---|---|---|
| What it is | AI-powered tele-stroke platform for advanced stroke diagnosis and disease management. | A widely used mobile medical reference application for healthcare professionals. |
| Category | Healthcare, Strokes, Diagnostics, Telehealth | HealthTech, MedTech, Clinical Decision Support, Mobile Health |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 1998 |
| Headquarters | Tel Aviv, Israel | San Mateo, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CVAid | Epocrates |
|---|---|---|
| Employees | 3 | Not published |
| Headcount growthLast 12 months | -44.7% | Not published |
| Total funding | $4.0M | $175M |
| Latest round | Series A | Acquisition |
| LinkedIn followers | 723 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CVAid | Epocrates |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 69/100 |
| Traction | 39/100 | 17/100 |
| Team | 70/100 | Not published |
| Search visibility | 30/100 | Not published |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (38/100) |
| Domain ratingLink authority, 0-100 | 23/100 | 71/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CVAid | Epocrates |
|---|---|---|
| Hosting | Not detected | AWS |
| CMS | Wix | Not detected |
CVAid vs Epocrates: common questions
Which is better, CVAid or Epocrates?
On our 0-100 score Epocrates rates higher (69/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do CVAid and Epocrates compare on the numbers?
Epocrates leads on our overall score (69/100 against 52/100), domain rating (71/100 against 23/100), funding raised ($175M against $4.0M).
Read the full CVAid review and pricing or the Epocrates review and pricing. You can also browse other CVAid alternatives we track.